Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Finerenone Reduces T2D Onset in HF With Preserved EF
MADRID, Spain — The nonsteroidal mineralocorticoid receptor antagonist (MRA) finerenone reduced the incidence of new-onset type 2 diabetes by approximately 25% in patients with heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF), according to a prespecified subgroup analysis…
English